MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
584.96%
Quick Ratio
584.96%
Cash Ratio
332.81%
Debt to Asset Ratio
43.97%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses
Others
Liabilities Breakdown
Accumulated deficit
Common stock, no par value unlim...
Additional paid-in capital
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
41,249
40,179
21,947
18,705
Accounts receivable, net
23,266
18,762
19,343
17,502
Prepaid expenses
3,635
3,461
1,399
1,421
Inventory
2,374
1,856
2,477
2,201
Other current assets
1,976
2,622
898
965
Total current assets
72,500
66,880
46,064
40,794
Non-current accounts receivable, net
2,587
4,251
2,454
3,314
Other non-current assets, net of amortization
666
691
743
768
Total non-current assets
3,253
4,942
3,197
4,082
Total assets
75,753
71,822
49,261
44,876
Accounts payable
5,516
6,281
5,866
5,941
Accrued liabilities
3,696
3,057
3,701
2,225
Contract liability - current
3,182
248
248
248
Total current liabilities
12,394
9,586
9,815
8,414
Term loan
-
-
18,206
18,206
Pik interest
-
-
1,271
1,271
Debt discount
-
-
100
113
Contract liability - long-term
20,917
24,561
24,561
24,561
Total long-term liabilities
20,917
24,561
43,938
43,925
Total liabilities
33,311
34,147
53,753
52,339
Common stock, no par value unlimited shares authorized 35,034 shares issued and outstanding (2025 34,163)
193,190
191,229
147,652
146,165
Additional paid-in capital
75,257
74,424
71,249
69,127
Accumulated deficit
-227,248
-229,221
-224,636
-223,998
Accumulated other comprehensive income
1,243
1,243
1,243
1,243
Total shareholders' equity/(deficit)
42,442
37,675
-4,492
-7,463
Total liabilities and shareholders' equity/(deficit)
75,753
71,822
49,261
44,876
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$41,249K
(120.52%↑ Y/Y)
Accounts receivable, net
$23,266K
(32.93%↑ Y/Y)
Prepaid expenses
$3,635K
(155.81%↑ Y/Y)
Inventory
$2,374K
(7.86%↑ Y/Y)
Other current assets
$1,976K
(104.77%↑ Y/Y)
Non-current accounts
receivable, net
$2,587K
(-21.94%↓ Y/Y)
Other non-current
assets, net of...
$666K
(-13.28%↓ Y/Y)
Total current assets
$72,500K
(77.72%↑ Y/Y)
Total non-current
assets
$3,253K
(-20.31%↓ Y/Y)
Total assets
$75,753K
(68.81%↑ Y/Y)
Total liabilities and
shareholders'...
$75,753K
(68.81%↑ Y/Y)
Total shareholders'
equity/(deficit)
$42,442K
(668.70%↑ Y/Y)
Total liabilities
$33,311K
(-36.36%↓ Y/Y)
Accumulated deficit
-$227,248K
(-1.45%↓ Y/Y)
Common stock, no par
value unlimited...
$193,190K
(32.17%↑ Y/Y)
Total long-term
liabilities
$20,917K
(-52.38%↓ Y/Y)
Total current
liabilities
$12,394K
(47.30%↑ Y/Y)
Additional paid-in capital
$75,257K
(8.87%↑ Y/Y)
Accumulated other
comprehensive income
$1,243K
(0.00%↑ Y/Y)
Contract liability -
long-term
$20,917K
(-14.84%↓ Y/Y)
Accounts payable
$5,516K
(-7.15%↓ Y/Y)
Accrued liabilities
$3,696K
(66.11%↑ Y/Y)
Contract liability -
current
$3,182K
(1183.06%↑ Y/Y)
Buy us a coffee
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)